Zylox Medical Device Overview
- Year Founded
-
2012
- Status
-
Public
- Employees
-
875
- Stock Symbol
-
02190
- Investments
-
2
- Share Price
-
$2.54
- (As of Monday Closing)
Zylox Medical Device General Information
Description
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). It derives majority of its revenue from PRC.
Contact Information
Website
www.zyloxtb.comCorporate Office
- No. 270, Shuyun Road, Cangqian Street
- Yuhang District
- Hangzhou, Zhejiang 311121
- China
Corporate Office
- No. 270, Shuyun Road, Cangqian Street
- Yuhang District
- Hangzhou, Zhejiang 311121
- China
Zylox Medical Device Stock Performance
As of 16-Jun-2025, Zylox Medical Device’s stock price is $2.54. Its current market cap is $808M with 318M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.54 | $2.48 | $1.21 - $2.81 | $808M | 318M | 834K | $0.04 |
Zylox Medical Device Financials Summary
As of 31-Dec-2024, Zylox Medical Device has a trailing 12-month revenue of $109M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 324,244 | 324,244 | 293,380 | 127,332 |
| Revenue | 109,049 | 109,049 | 74,595 | 49,608 |
| EBITDA | 11,001 | 11,001 | (16,983) | (27,044) |
| Net Income | 13,972 | 13,972 | (11,129) | (16,862) |
| Total Assets | 472,947 | 472,947 | 476,215 | 471,598 |
| Total Debt | 12,453 | 12,453 | 7,883 | 2,029 |
Zylox Medical Device Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Zylox Medical Device Comparisons
Industry
Financing
Details
Zylox Medical Device Competitors (1)
One of Zylox Medical Device’s competitors is Cordis, a Private Equity-Backed company based in Miami Lakes, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cordis | Private Equity-Backed | Miami Lakes, FL |
Zylox Medical Device Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Zylox Medical Device Patents
Zylox Medical Device Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20150051242-A1 | Rafamycin analogs and methods for making same | Inactive | 26-Oct-2012 | ||
| CA-2863256-A1 | Self-expanding stent | Inactive | 26-Oct-2012 | ||
| AU-2013337199-A1 | Self-expanding stent | Inactive | 26-Oct-2012 | ||
| JP-2015532188-A | Self-expanding stent | Pending | 26-Oct-2012 | ||
| EP-2809277-A1 | Self-expanding stent | Inactive | 26-Oct-2012 | A61F2/915 |
Zylox Medical Device Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Zylox Medical Device Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Zylox Medical Device Investments (2)
Zylox Medical Device’s most recent deal was a PIPE with Avinger for . The deal was made on 06-Mar-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Avinger | 06-Mar-2024 | PIPE | Other Devices and Supplies | ||
| Wire Science | 18-Jan-2021 | Early Stage VC | Surgical Devices |
Zylox Medical Device ESG
Risk Overview
Risk Rating
Updated May, 13, 2025
29.87 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,673
Rank
Percentile
Healthcare
Industry
of 564
Rank
Percentile
Medical Devices
Subindustry
of 196
Rank
Percentile
Zylox Medical Device FAQs
-
When was Zylox Medical Device founded?
Zylox Medical Device was founded in 2012.
-
Where is Zylox Medical Device headquartered?
Zylox Medical Device is headquartered in Hangzhou, China.
-
What is the size of Zylox Medical Device?
Zylox Medical Device has 875 total employees.
-
What industry is Zylox Medical Device in?
Zylox Medical Device’s primary industry is Surgical Devices.
-
Is Zylox Medical Device a private or public company?
Zylox Medical Device is a Public company.
-
What is Zylox Medical Device’s stock symbol?
The ticker symbol for Zylox Medical Device is 02190.
-
What is the current stock price of Zylox Medical Device?
As of 16-Jun-2025 the stock price of Zylox Medical Device is $2.54.
-
What is the current market cap of Zylox Medical Device?
The current market capitalization of Zylox Medical Device is $808M.
-
What is Zylox Medical Device’s current revenue?
The trailing twelve month revenue for Zylox Medical Device is $109M.
-
Who are Zylox Medical Device’s competitors?
Cordis is a competitor of Zylox Medical Device.
-
What is Zylox Medical Device’s annual earnings per share (EPS)?
Zylox Medical Device’s EPS for 12 months was $0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
